Anya Sahni is an illustrator and was The Transmitter’s art intern in the summer of 2024. She is an undergraduate student at Rensselaer Polytechnic Institute, where she studies neuroscience and art.
Anya Sahni
Art intern
The Transmitter
From this contributor
Thinking about thinking: AI offers theoretical insights into human memory
We need a new conceptual framework for understanding cognitive functions—particularly how globally distributed brain states are formed and maintained for hours.
Thinking about thinking: AI offers theoretical insights into human memory
By
Terrence Sejnowski
5 May 2025 | 7 min read
Revisiting sex and gender in the brain
To conduct scientifically accurate and socially responsible research, it is useful to think of “sex” as a complex, multifactorial and context-dependent variable.
Revisiting sex and gender in the brain
By
Marija Kundakovic
28 January 2025 | 8 min read
Say what? The Transmitter’s top quotes of 2024
“We’ve cured mouse-heimer’s thousands of times...”—find out who said this to a Transmitter reporter, and read our other favorite quotes from the past year.
Say what? The Transmitter’s top quotes of 2024
By
The Transmitter
23 December 2024 | 2 min read
Neural manifolds: Latest buzzword or pathway to understand the brain?
When you cut away the misconceptions, neural manifolds present a conceptually appropriate level at which systems neuroscientists can study the brain.
Neural manifolds: Latest buzzword or pathway to understand the brain?
By
Matthew Perich
2 October 2024 | 8 min read
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
By
Olivia Gieger
4 September 2024 | 6 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read